Clinical trial
Galantamine Treatment for Nonfluent Aphasia in Stroke Patients
NCT01129479 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Galantamine Treatment for Nonfluent Aphasia in Stroke Patients
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2004
- Completion date
- December 31, 2007
- Enrollment
- 8 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.